Ionis Pharmaceuticals, AstraZeneca get FDA approval for rare genetic disease treatment
Ionis Pharmaceuticals, AstraZeneca get FDA approval for rare genetic disease treatment
#earnings before the open tomorrow https://t.co/lObOE0dgsr $GM $CVS $KHC $RCL $SMG $EXPI $LL $MPC $MPLX $TXMD $CLVS $TUP $FUN $BWA $HZNP $DNOW $EMR $EVRI $HMC $GEO $VMC $AEIS $MAC $CAMT $ETR $SPR $CRL $BCOR $NYT $HFC $SMP $OESX $EDIT $ENBL $CRTO $ABC $VIRT $APO $IONS $TT $MKL https://t.co/nyQvA2K3fE
6.64BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US4622221004
CUSIP
462222100
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
25.70
Book Value
2.99
Dividend Share
-
Dividend Yield
-
Earnings Share
-2.99
Wall Street Target Price
57.89
EPS Estimate Current Year
-2.29
EPS Estimate Next Year
-1.87
EPS Estimate Current Quarter
-1.0317
EPS Estimate Next Quarter
-0.87
Most Recent Quarter
-
Revenue TTM
717,252,992
Gross Profit TTM
-181,148,000
EBITDA
-460,854,016
Profit Margin
-63.86%
Return On Assets TTM
-10.59%
Return On Equity TTM
-118.62%
Revenue Per Share TTM
4.694
Qtly Revenue Growth YOY
10.10%
Diluted Eps TTM
-2.99
Qtly Earnings Growth YOY
-43.70%
Trailing PE
0.00
Forward PE
90
Price Sales TTM
9.2599
Price Book MRQ
13.9612
Enterprise Value Revenue
8
Enterprise Value EBITDA
-22
81.44
1.94%559.55
0.72%271.40
0.64%466.36
0.52%547.60
0.00%203.85
0.00%99.06
-1.90%157.11
-1.81%311.12
-1.49%545.01
-0.50%